Xponance, Inc. Heron Therapeutics, Inc. Transaction History
Xponance, Inc.
- $11.7 Billion
- Q2 2025
A detailed history of Xponance, Inc. transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Xponance, Inc. holds 11,893 shares of HRTX stock, worth $15,936. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,893Holding current value
$15,936% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding HRTX
# of Institutions
185Shares Held
130MCall Options Held
1.56MPut Options Held
27.1K-
Rubric Capital Management LP New York, NY26.7MShares$35.8 Million1.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.47MShares$11.4 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$11.2 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$10.5 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$9.36 Million24.86% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $159M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...